98%
921
2 minutes
20
Objective: To assess differences in maternal and child outcomes in studies comparing reduced routine antenatal visit schedules with traditional schedules.
Data Sources: A search was conducted of PubMed, Cochrane databases, EMBASE, CINAHL, and ClinicalTrials.gov through February 12, 2022, searching for antenatal (prenatal) care, pregnancy, obstetrics, telemedicine, remote care, smartphones, telemonitoring, and related terms, as well as primary study designs. The search was restricted to high-income countries.
Methods Of Study Selection: Double independent screening was done in Abstrackr for studies comparing televisits and in-person routine antenatal care visits for maternal, child, health care utilization, and harm outcomes. Data were extracted into SRDRplus with review by a second researcher.
Tabulation, Integration, And Results: Five randomized controlled trials and five nonrandomized comparative studies compared reduced routine antenatal visit schedules with traditional schedules. Studies did not find differences between schedules in gestational age at birth, likelihood of being small for gestational age, likelihood of a low Apgar score, likelihood of neonatal intensive care unit admission, maternal anxiety, likelihood of preterm birth, and likelihood of low birth weight. There was insufficient evidence for numerous prioritized outcomes of interest, including completion of the American College of Obstetricians and Gynecologists-recommended services and patient experience measures.
Conclusion: The evidence base is limited and heterogeneous and allowed few specific conclusions. Reported outcomes included, for the most part, standard birth outcomes that do not have strong plausible biological connection to structural aspects of antenatal care. The evidence did not find negative effects of reduced routine antenatal visit schedules, which may support implementation of fewer routine antenatal visits. However, to enhance confidence in this conclusion, future research is needed, particularly research that includes outcomes of most importance and relevance to changing antenatal care visits.
Systematic Review Registration: PROSPERO, CRD42021272287.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/AOG.0000000000005193 | DOI Listing |
Turk J Obstet Gynecol
September 2025
University of Health Sciences Türkiye, Ankara City Hospital, Department of Obstetrics and Gynecology, Ankara, Türkiye.
Objective: Toxoplasmosis is an intracellular parasite and one of the most common congenital infections. Currently, there is no clear consensus on routine screening for toxoplasma infection during pregnancy. This study aimed to discuss the results of antenatal toxoplasma screening in a tertiary center.
View Article and Find Full Text PDFTransfus Clin Biol
September 2025
Department of Obstetrics & Gynecology, All India Institute of Medical Sciences, Jodhpur, Rajasthan. Electronic address:
Background: Red-cell alloimmunisation is a preventable driver of haemolytic disease of the fetus and newborn, yet most risk scores rely on single-parameter thresholds and overlook clinically important heterogeneity.
Objective: To uncover latent phenotypes among sensitised pregnancies by clustering routinely collected clinical and immunohaematologic variables.
Methods: We retrospectively analysed 2084 antenatal records (2020 - 2021).
Biomed Res Int
September 2025
Department of Biostatistics and Medical Informatics, Faculty of Medicine, Kahramanmaraş Sütçü Imam University, Kahramanmaraş, Türkiye.
In countries like Somalia, where health infrastructure is inadequate and malaria is endemic, immunosuppression during pregnancy increases the risk of placental malaria; this, in turn, leads to anemia, low birth weight, preterm delivery, and stillbirth, causing severe complications that pose a life-threatening risk to both the mother and fetus. The aim of this study was to investigate the prevalence and associated factors of malaria parasitemia among pregnant women attending the obstetric clinic of a tertiary hospital in Somalia. This cross-sectional study, conducted from November 2022 to January 2023 at a tertiary hospital in Mogadishu, involved 398 pregnant women.
View Article and Find Full Text PDFInt J Gynaecol Obstet
September 2025
Center for Infectious Disease Research in Zambia, Lusaka, Zambia.
Objective: Syphilis and HIV in pregnancy contribute to adverse birth outcomes in Africa. Benzathine penicillin G remains an effective treatment for syphilis in pregnancy, yet gaps persist in timely treatment. The aim of this study was to compare factors associated with adverse birth outcomes among pregnant women diagnosed with syphilis in health facilities according to their HIV status.
View Article and Find Full Text PDFTrauma Violence Abuse
September 2025
University of Queensland, Brisbane, South Brisbane, Australia.
Domestic and family violence (DFV) disproportionately affects women in the perinatal period. Routine DFV screening is known to improve DFV identification, however, it is crucial to understand women's views of routine DFV inquiry and their post-disclosure needs specific to the maternity care setting. The aim of this qualitative meta-synthesis was to explore perinatal women's perceptions and experiences of routine DFV screening and post-disclosure practices in antenatal care.
View Article and Find Full Text PDF